Outlook: Market Access in Australia

Australia is a country that has challenged pharmaceutical manufacturers in recent years with extensive government reforms in drug pricing, unpredictability around reimbursement and pricing decisions, and other structural changes. Despite these challenges, the Australian market still offers a number of opportunities for manufacturers.

This BioPharmaceutical International article by Michael J. Kuchenreuther and Jill E. Sackman looks at those opportunities.